Company

Advisors

Hakon Hakonarson, M.D., Ph.D.

Dr. Hakonarson is a Professor of Pediatrics at The Children’s Hospital of Philadelphia (CHOP) and Perelman School of Medicine at the University of Pennsylvania. At CHOP, he is the Director for the Center for Applied Genomics (CAG) where he and his team are focused on the identification of genetic variants that underlie complex medical disorders in children and differential response to medications. Dr. Hakonarson is a fellowship trained pediatric pulmonologist and previously held multiple executive positions at deCODE genetics.

Stephen P. Spielberg, M.D., Ph.D.

Dr. Spielberg’s 40-year career in pediatrics, clinical pharmacology, drug safety, and pharmacogenomics has spanned time in academia, the pharmaceutical industry, and government. He has served as Dean of the Dartmouth Medical School, VP for Pediatric Drug Development at JNJ, and Deputy Commissioner for Medical Products at the US FDA. He is Editor-in-Chief of Therapeutic Innovation and Regulatory Science (the journal of the Drug Information Association), serves on the Advisory Board of CASMI (Centre for Advancement of Sustainable Medical Innovation), and is a Medical Sciences Trustee on the Board of the U.S. Pharmacopeia.

Dr. Spielberg was educated at Princeton (AB, Biology), University of Chicago (MD-PhD (Pharmacology)), Children’s Hospital Boston (Pediatric Residency), and NICHD (genetics fellowship). He has published over 140 scientific papers, and received numerous awards for his work advancing pediatric therapeutics.